Venture Certified
| 벤처투자유형 | 2022-12-28 ~ 2025-12-27 | 20221228010029 | 2022-12-28 |
| 벤처투자유형 | 2025-12-28 ~ 2028-12-27 | 20251216010038 | 2022-12-28 |
Revenue CAGR +44.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 10.3B | 9.1B | 4.9B |
| Operating Profit | -18.5B | -12.2B | -5.0B |
| Net Profit | -16.6B | -10.6B | -4.2B |
| Total Assets | 73.1B | 10.6B | 12.1B |
| Total Liabilities | 13.8B | 8.8B | 0.6B |
| Total Equity | 59.3B | 1.9B | 11.4B |
Operating Loss: Op. profit -18B
3 Consecutive Years of Net Loss
▲ 47.6%
▼ 114.8%
▼ 51.5%
▼ 90.2%
▲ 90.7%
| Name | Position | Role |
|---|---|---|
| 신민경 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 성남시",
"ceo_name": "신민경",
"certificate": [
{
"cert_number": "20221228010029",
"changes": "",
"disclosure_date": "2022-12-28",
"first_cert_date": "2022-12-28",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2022-12-28 ~ 2025-12-27"
},
{
"cert_number": "20251216010038",
"changes": "",
"disclosure_date": "2025-12-16",
"first_cert_date": "2022-12-28",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2025-12-28 ~ 2028-12-27"
}
],
"company_name": "(주)셀타스퀘어",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 215000000,
"cost_of_sales": 0,
"current_assets": 1021395000,
"current_liabilities": 60586000,
"gross_profit": 493833000,
"net_income": -417353000,
"net_income_bs": -417353000,
"non_current_assets": 184025000,
"non_current_liabilities": 0,
"non_operating_expenses": 488000,
"non_operating_income": 84990000,
"operating_profit": -501855000,
"revenue": 493833000,
"sga_expenses": 995688000,
"total_assets": 1205420000,
"total_equity": 1144834000,
"total_liabilities": 60586000
},
"2023": {
"capital_stock": 217500000,
"cost_of_sales": 0,
"current_assets": 864990000,
"current_liabilities": 375520000,
"gross_profit": 905053000,
"net_income": -1057434000,
"net_income_bs": -1057434000,
"non_current_assets": 197399000,
"non_current_liabilities": 500000000,
"non_operating_expenses": 11647000,
"non_operating_income": 170947000,
"operating_profit": -1216734000,
"revenue": 905053000,
"sga_expenses": 2121787000,
"total_assets": 1062389000,
"total_equity": 186869000,
"total_liabilities": 875520000
},
"2024": {
"capital_stock": 325053000,
"cost_of_sales": 0,
"current_assets": 7144399000,
"current_liabilities": 1062901000,
"gross_profit": 1032553000,
"net_income": -1659928000,
"net_income_bs": -1659928000,
"non_current_assets": 163261000,
"non_current_liabilities": 316713000,
"non_operating_expenses": 35986000,
"non_operating_income": 222200000,
"operating_profit": -1846142000,
"revenue": 1032553000,
"sga_expenses": 2878695000,
"total_assets": 7307660000,
"total_equity": 5928046000,
"total_liabilities": 1379614000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "1,999,999,500",
"changes": "1,999,999,500",
"date": "2024-12-24"
},
{
"amount": "800,000,000",
"changes": "800,000,000",
"date": "2022-11-15"
}
],
"main_products": "AI/Digital transformation 기반 의약품 전주기 안전성 관리 플랫폼 서비스",
"phone": "010-5126-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |